TRDA Reports $255M Cash Runway, Positive ELEVATE-44-201 Cohort 1 Safety & Functional Benefits, Data Updates Planned 2026
Entrada Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.91
-14% in 7d after detection
Post-detection moves
1h
—
1d
-0.1%
3d
+3.9%
7d
-14%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS